Thomas W. Wakefield

26.4k total citations · 5 hit papers
335 papers, 17.8k citations indexed

About

Thomas W. Wakefield is a scholar working on Internal Medicine, Surgery and Hematology. According to data from OpenAlex, Thomas W. Wakefield has authored 335 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Internal Medicine, 169 papers in Surgery and 98 papers in Hematology. Recurrent topics in Thomas W. Wakefield's work include Venous Thromboembolism Diagnosis and Management (236 papers), Diagnosis and Treatment of Venous Diseases (99 papers) and Blood Coagulation and Thrombosis Mechanisms (94 papers). Thomas W. Wakefield is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (236 papers), Diagnosis and Treatment of Venous Diseases (99 papers) and Blood Coagulation and Thrombosis Mechanisms (94 papers). Thomas W. Wakefield collaborates with scholars based in United States, United Kingdom and Canada. Thomas W. Wakefield's co-authors include Peter K. Henke, Daniel D. Myers, Shirley K. Wrobleski, James C. Stanley, Denisa D. Wagner, Lazar J. Greenfield, Tobias A. Fuchs, Alexander Brill, Angela E. Hawley and Bo Eklöf and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Thomas W. Wakefield

326 papers receiving 17.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular DNA traps promote thrombosis

2010 1.9k citations Tobias A. Fuchs, Alexander Brill et al. Proceedings of the National Academy of Sciences profile →
Revision of the CEAP classification for chronic venous disorders: Consensus statement

2004 1.3k citations Bo Eklöf, Frank T. Padberg et al. Journal of Vascular Surgery profile →
Multidetector Computed Tomography for Acute Pulmonary Embolism

2006 1.0k citations Thomas W. Wakefield et al. profile →
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum

2011 966 citations Michael C. Dalsing, Bo Eklöf et al. Journal of Vascular Surgery profile →
A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method

2010 428 citations Peter K. Henke, Thomas W. Wakefield et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas W. Wakefield	10.2k	7.4k	3.7k	3.7k	3.1k	335	17.8k
Peter K. Henke	4.8k 0.5×	5.3k 0.7×	3.7k 1.0×	2.2k 0.6×	4.5k 1.4×	367	13.3k
Ingrid Pabinger	9.3k 0.9×	2.5k 0.3×	6.1k 1.6×	10.5k 2.8×	1.6k 0.5×	541	20.3k
Charles W. Francis	10.0k 1.0×	3.8k 0.5×	6.4k 1.7×	2.9k 0.8×	2.3k 0.7×	170	15.6k
Cihan Ay	7.6k 0.8×	2.0k 0.3×	4.7k 1.3×	3.5k 1.0×	1.3k 0.4×	384	12.8k
Nigel S. Key	5.1k 0.5×	2.3k 0.3×	3.2k 0.9×	9.6k 2.6×	1.6k 0.5×	348	19.3k
Antonio Girolami	6.4k 0.6×	3.3k 0.5×	4.0k 1.1×	7.5k 2.0×	1.5k 0.5×	553	13.9k
Jan W. ten Cate	4.2k 0.4×	2.1k 0.3×	2.5k 0.7×	3.1k 0.8×	971 0.3×	110	7.9k
Beng H. Chong	3.1k 0.3×	3.9k 0.5×	2.1k 0.6×	5.6k 1.5×	927 0.3×	211	11.1k
Victor J. Marder	2.3k 0.2×	2.3k 0.3×	2.0k 0.5×	3.8k 1.0×	3.1k 1.0×	225	10.2k
Theodore E. Warkentin	11.7k 1.2×	18.7k 2.5×	5.3k 1.4×	10.3k 2.8×	851 0.3×	326	25.1k

Countries citing papers authored by Thomas W. Wakefield

Since Specialization

Citations

This map shows the geographic impact of Thomas W. Wakefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Wakefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Wakefield more than expected).

Fields of papers citing papers by Thomas W. Wakefield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Wakefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Wakefield. The network helps show where Thomas W. Wakefield may publish in the future.

Co-authorship network of co-authors of Thomas W. Wakefield

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Wakefield. A scholar is included among the top collaborators of Thomas W. Wakefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Wakefield. Thomas W. Wakefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, David, et al.. (2023). An ultrasound imaging and computational fluid dynamics protocol to assess hemodynamics in iliac vein compression syndrome. Journal of Vascular Surgery Venous and Lymphatic Disorders. 11(5). 1023–1033.e5. 5 indexed citations

Melvin, William J., Christopher O. Audu, Wei-Sheng Wu, et al.. (2022). The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood. 141(7). 725–742. 10 indexed citations

Audu, Christopher O., et al.. (2020). Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. Journal of Vascular Surgery Venous and Lymphatic Disorders. 8(2). 299–305. 17 indexed citations

Spagou, Konstantina, Marina Kafeza, Michael Kyriakides, et al.. (2018). Deep Vein Thrombosis Exhibits Characteristic Serum and Vein Wall Metabolic Phenotypes in the Inferior Vena Cava Ligation Mouse Model. European Journal of Vascular and Endovascular Surgery. 55(5). 703–713. 18 indexed citations

Jacobs, Benjamin, Andrea Obi, & Thomas W. Wakefield. (2016). Diagnostic biomarkers in venous thromboembolic disease. Journal of Vascular Surgery Venous and Lymphatic Disorders. 4(4). 508–517. 26 indexed citations

Devata, Sumana, Suman L. Sood, William G. Kramer, et al.. (2015). First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile. Blood. 126(23). 1004–1004. 15 indexed citations

Díaz, José A., Angela E. Hawley, Elise DeRoo, et al.. (2013). Galectin-3 Binding Protein and Galectin-3: Novel Factors Promoting Venous Thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 1(1). 102–102. 1 indexed citations

Díaz, José A., Shirley K. Wrobleski, Angela E. Hawley, et al.. (2011). Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis. Journal of Visualized Experiments. 11 indexed citations

Díaz, José A., Diana Farris, Angela E. Hawley, et al.. (2011). Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. Journal of Vascular Surgery. 55(3). 815–822. 33 indexed citations

10.

Fuchs, Tobias A., Alexander Brill, Daniel Duerschmied, et al.. (2010). Extracellular DNA traps promote thrombosis. Proceedings of the National Academy of Sciences. 107(36). 15880–15885. 1872 indexed citations breakdown →

11.

Wakefield, Thomas W., Daniel D. Myers, & Peter K. Henke. (2008). Mechanisms of Venous Thrombosis and Resolution. Arteriosclerosis Thrombosis and Vascular Biology. 28(3). 387–391. 293 indexed citations

12.

McLafferty, Robert B., Joanne M. Lohr, Joseph A. Caprini, et al.. (2007). Results of the National Pilot Screening Program for Venous Disease by the American Venous Forum. Journal of Vascular Surgery. 45(1). 142–148.e4. 35 indexed citations

13.

Henke, Peter K., Charles G. Pearce, Erin Lynch, et al.. (2006). Targeted Deletion of CCR2 Impairs Deep Vein Thombosis Resolution in a Mouse Model. The Journal of Immunology. 177(5). 3388–3397. 97 indexed citations

14.

Upchurch, Gilbert R., Peter K. Henke, Matthew J. Eagleton, et al.. (2002). Pediatric splanchnic arterial occlusive disease: Clinical relevance and operative treatment. Journal of Vascular Surgery. 35(5). 860–867. 15 indexed citations

15.

Knipp, Brian S., David Peterson, Sanjay Rajagopalan, et al.. (2002). Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. Journal of Vascular Surgery. 35(2). 363–367. 12 indexed citations

16.

Cardneau, Jeffry D., Peter K. Henke, Gilbert R. Upchurch, et al.. (2001). Efficacy and durability of autogenous saphenous vein conduits for lower extremity arterial reconstructions in preadolescent children. Journal of Vascular Surgery. 34(1). 34–40. 40 indexed citations

17.

Sarkar, Rajabrata, et al.. (2000). Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms. Journal of Vascular Surgery. 31(5). 863–869. 107 indexed citations

18.

Henke, Peter K., Robert M. Strieter, Jonathan S. Bromberg, et al.. (2000). Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis,. The Journal of Immunology. 164(4). 2131–2141. 55 indexed citations

19.

Wakefield, Thomas W.. (2000). Low molecular weight heparin therapy: an evaluation of clinical trials evidence. Journal of Vascular Surgery. 32(4). 831–831.

20.

Stanley, James C., Thomas W. Wakefield, Linda M. Graham, et al.. (1986). Clinical importance and management of splanchnic artery aneurysms. Journal of Vascular Surgery. 3(5). 836–840. 324 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact